97 related articles for article (PubMed ID: 10333454)
41. Tumor necrosis factor alpha and interferon gamma--induced cell growth arrest is mediated via insulin-like growth factor binding protein-3.
Katz J; Nasatzky E; Werner H; Le Roith D; Shemer J
Growth Horm IGF Res; 1999 Jun; 9(3):174-8. PubMed ID: 10502453
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
44. [Influence of SNCG transfection on the effectiveness of anti-tumor drugs in PC-3 cell lines].
Chen JL; Wang B; Zhang LR; He BS; Pan YQ; Zeng QD; Jiang HX; Wang SK
Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1077-82. PubMed ID: 19157226
[TBL] [Abstract][Full Text] [Related]
45. A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.
Arizono Y; Yoshikawa H; Naganuma H; Hamada Y; Nakajima Y; Tasaka K
Br J Cancer; 2003 Jan; 88(2):298-306. PubMed ID: 12610517
[TBL] [Abstract][Full Text] [Related]
46. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
[TBL] [Abstract][Full Text] [Related]
47. Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
Can J Vet Res; 1995 Jan; 59(1):67-9. PubMed ID: 7704845
[TBL] [Abstract][Full Text] [Related]
48. Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line.
Sano J; Nagafuchi S; Yamazaki J; Oguma K; Kano R; Hasegawa A
Res Vet Sci; 2005 Dec; 79(3):197-201. PubMed ID: 15893350
[TBL] [Abstract][Full Text] [Related]
49. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M
Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
[TBL] [Abstract][Full Text] [Related]
50. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
51. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
52. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours.
Tateyama S; Priosoeryanto BP; Yamaguchi R; Uchida K; Ogiwara K; Suchiya AT
Res Vet Sci; 1995 Nov; 59(3):275-7. PubMed ID: 8588106
[TBL] [Abstract][Full Text] [Related]
53. Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro.
Hill BT; Hosking LK; Shellard SA; Whelan RD
Cancer Chemother Pharmacol; 1989; 23(3):140-4. PubMed ID: 2924371
[TBL] [Abstract][Full Text] [Related]
54. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
Hill BT; Whelan RD
J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
[TBL] [Abstract][Full Text] [Related]
55. Feline mammary carcinomas as a model for human breast cancer. I. Sensitivity of mammary tumor cells in culture to cytostatic drugs. A preliminary investigation of a predictive test.
Prop FJ; Weijer K; Spies J; Souw L; Peters K; Erich T; Rijnhart P; Misdorp W
Anticancer Res; 1986; 6(5):989-94. PubMed ID: 3800339
[TBL] [Abstract][Full Text] [Related]
56. Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.
Hand AM; Husgafvel-Pursiainen K; Pelin K; Vallas M; Suitiala T; Ekman A; Mattson M; Mattson K; Linnainmaa K
Anticancer Drugs; 1992 Dec; 3(6):687-94. PubMed ID: 1288739
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of a feline mammary carcinoma cell line.
Norval M; Maingay J; Else RW
Res Vet Sci; 1985 Sep; 39(2):157-64. PubMed ID: 3906801
[TBL] [Abstract][Full Text] [Related]
58. Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Küpeli S; Beksac M; Küpeli B; Baltaci S; Süzer O
Int Urol Nephrol; 1997; 29(4):421-6. PubMed ID: 9405998
[TBL] [Abstract][Full Text] [Related]
59. Establishment and characterization of a new cell line derived from feline mammary tumor.
Muleya JS; Nakaichi M; Sugahara J; Taura Y; Murata T; Nakama S
J Vet Med Sci; 1998 Aug; 60(8):931-5. PubMed ID: 9764406
[TBL] [Abstract][Full Text] [Related]
60. Reproductive potential of vincristine-treated multinucleate carcinoma cells.
Tennyson GS; Burbach BJ; Lane BP
Cancer Treat Rep; 1983 Dec; 67(12):1113-4. PubMed ID: 6652628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]